(Q44761150)

6 December 2017

title

CDKN2A germline mutations in familial pancreatic cancer (English)

1 reference

6 December 2017

10

1 reference

6 December 2017

Detlef K Bartsch

1

1 reference

6 December 2017

Mercedes Sina-Frey

2

1 reference

6 December 2017

Sven Lang

3

1 reference

6 December 2017

Anja Wild

4

1 reference

6 December 2017

Berthold Gerdes

5

1 reference

6 December 2017

Peter Barth

6

1 reference

6 December 2017

Ralf Kress

7

1 reference

6 December 2017

Robert Grützmann

8

1 reference

6 December 2017

Mario Colombo-Benkmann

9

1 reference

6 December 2017

Stephan A Hahn

11

1 reference

6 December 2017

Matthias Rothmund

12

1 reference

6 December 2017

Harald Rieder

13

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

6 December 2017

1 reference

6 December 2017

volume

236

1 reference

6 December 2017

issue

6

1 reference

6 December 2017

page(s)

730-737

1 reference

Systemic cancer and the FAMMM syndrome

6 December 2017

cites work

1 reference

12 December 2020

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

1 reference

12 December 2020

Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations

1 reference

12 December 2020

Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group

1 reference

12 December 2020

Inherited pancreatic cancer: surveillance and treatment strategies for affected families

1 reference

12 December 2020

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions

1 reference

12 December 2020

Update of Familial Pancreatic Cancer in Germany

1 reference

12 December 2020

A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.

1 reference

12 December 2020

Genetics of pancreatic cancer. From genes to families.

1 reference

12 December 2020

Hereditary pancreatitis and familial pancreatic cancer

1 reference

12 December 2020

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

1 reference

12 December 2020

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

1 reference

12 December 2020

Screening for CDKN2A mutations in hereditary melanoma

1 reference

12 December 2020

p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer

1 reference

12 December 2020

Prognostic factors in ductal pancreatic cancer

1 reference

12 December 2020

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

1 reference

12 December 2020

Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature

1 reference

12 December 2020

Increased risk of cancer in the Peutz-Jeghers syndrome

1 reference

12 December 2020

Multiple primary tumors as an indicator for p16INK4a germline mutations in pancreatic cancer patients?

1 reference

12 December 2020

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

1 reference

12 December 2020

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations

1 reference

12 December 2020

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families

1 reference

12 December 2020

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

1 reference

12 December 2020

The risk of upper gastrointestinal cancer in familial adenomatous polyposis

1 reference

12 December 2020

Familial pancreatic cancer: clinicopathologic study of 18 nuclear families.

1 reference

12 December 2020

[Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people]

1 reference

12 December 2020

Familial pancreatic cancer

1 reference

12 December 2020

Medical genetic study of eight pancreatic cancer-prone families

1 reference

12 December 2020

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

12 December 2020

Germline p16 mutations in familial melanoma

1 reference

12 December 2020

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

12 December 2020

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

12 December 2020

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

1 reference

12 December 2020

Heredity and malignant melanoma: implications for early cancer detection

1 reference

12 December 2020

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia

1 reference

12 December 2020

Genetics and pancreatic cancer

1 reference

12 December 2020

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

1 reference

12 December 2020

Familial pancreatic cancer

1 reference

12 December 2020

Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online.

1 reference

12 December 2020

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene

1 reference

12 December 2020

Mutations associated with familial melanoma impair p16INK4 function.

1 reference

12 December 2020

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.

1 reference

12 December 2020

10.1097/00000658-200212000-00005

Identifiers

DOI

1 reference

6 December 2017

0 references

1 reference